<SEC-DOCUMENT>0001193125-19-173104.txt : 20190614
<SEC-HEADER>0001193125-19-173104.hdr.sgml : 20190614
<ACCEPTANCE-DATETIME>20190614091401
ACCESSION NUMBER:		0001193125-19-173104
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20190614
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20190614
DATE AS OF CHANGE:		20190614

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			MIMEDX GROUP, INC.
		CENTRAL INDEX KEY:			0001376339
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		IRS NUMBER:				262792552
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-35887
		FILM NUMBER:		19897695

	BUSINESS ADDRESS:	
		STREET 1:		1775 W OAK COMMONS COURT, NE
		CITY:			MARIETTA
		STATE:			GA
		ZIP:			30062
		BUSINESS PHONE:		(770) 651-9100

	MAIL ADDRESS:	
		STREET 1:		1775 W OAK COMMONS COURT, NE
		CITY:			MARIETTA
		STATE:			GA
		ZIP:			30062

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Alynx, Co.
		DATE OF NAME CHANGE:	20060922
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d765454d8k.htm
<DESCRIPTION>8-K
<TEXT>
<HTML><HEAD>
<TITLE>8-K</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>UNITED STATES </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>SECURITIES AND EXCHANGE COMMISSION </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>WASHINGTON, DC 20549 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>FORM <FONT
STYLE="white-space:nowrap">8-K</FONT> </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>CURRENT
REPORT </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>PURSUANT TO SECTION 13 OR 15(d) </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>OF THE SECURITIES EXCHANGE ACT OF 1934 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Date of Report (Date of earliest event reported): June&nbsp;14, 2019 </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman" ALIGN="center"><B>MIMEDX GROUP, INC. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Exact name of registrant as specified in charter) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>
<TD WIDTH="34%"></TD>
<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center"><B>Florida</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B><FONT STYLE="white-space:nowrap">001-35887</FONT></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B><FONT STYLE="white-space:nowrap">26-279552</FONT></B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(State or other jurisdiction</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>of incorporation)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Commission</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>file number)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(IRS Employer</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Identification No.)</B></P></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>1775 West Oak Commons Ct., NE, Marietta GA 30062 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Address of Principal Executive Offices) (Zip Code) </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Registrant&#146;s telephone number, including area code: (770) <FONT STYLE="white-space:nowrap">651-9100</FONT> </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box below if the Form <FONT STYLE="white-space:nowrap">8-K</FONT> filing is intended to simultaneously satisfy the filing obligation of
the registrant under any of the following provisions (<I>see</I> General Instruction A.2. below): </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Soliciting material pursuant to Rule <FONT STYLE="white-space:nowrap">14a-12</FONT> under the Exchange Act (17
CFR <FONT STYLE="white-space:nowrap">240.14a-12)</FONT> </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><FONT STYLE="white-space:nowrap">Pre-commencement</FONT> communications pursuant to Rule <FONT
STYLE="white-space:nowrap">14d-2(b)</FONT> under the Exchange Act (17 CFR <FONT STYLE="white-space:nowrap">240.14d-2(b))</FONT> </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><FONT STYLE="white-space:nowrap">Pre-commencement</FONT> communications pursuant to Rule <FONT
STYLE="white-space:nowrap">13e-4(c)</FONT> under the Exchange Act (17 CFR <FONT STYLE="white-space:nowrap">240.13e-4(c))</FONT> </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Securities registered pursuant to Section&nbsp;12(b) of the Act: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>
<TD WIDTH="34%"></TD>
<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Title of each&nbsp;class</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Trading</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Symbol(s)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Name of each exchange</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>on which registered</B></P></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center"><B>None</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>n/a</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>n/a</B></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of
1933 (&#167; 230.405) or Rule <FONT STYLE="white-space:nowrap">12b-2</FONT> of the Securities Exchange Act of 1934 (&#167; <FONT STYLE="white-space:nowrap">240.12b-2).</FONT> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Emerging growth company&nbsp;&nbsp;&#9744; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If an emerging
growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&nbsp;13(a) of the Exchange
Act.&nbsp;&nbsp;&#9744; </P> <P STYLE="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Item&nbsp;8.01 Other Events. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On June&nbsp;14, 2019, MiMedx Group, Inc. (the <B><I>&#147;Company</I></B>&#148;) issued a press release urging shareholders of the Company to vote for the
Company&#146;s three director nominees, K. Todd Newton, Dr.&nbsp;Kathleen Behrens Wilsey and Timothy R. Wright, for election at the Company&#146;s 2018 annual meeting of shareholders to be held on June&nbsp;17, 2019. A copy of the press release is
attached hereto as Exhibit 99.1 and is incorporated herein by reference. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Item&nbsp;9.01 Financial Statements and Exhibits. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(d) Exhibits </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD WIDTH="92%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman"><B>Exhibit</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Number</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Description</B></P></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d765454dex991.htm">Press release of MiMedx Group, Inc., dated June&nbsp;14, 2019. </A></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SIGNATURES </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned
hereunto duly authorized. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="46%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>
<TD VALIGN="bottom"></TD>
<TD WIDTH="2%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="45%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date: June&nbsp;14, 2019</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"><B>MIMEDX GROUP, INC.</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Edward J. Borkowski</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Interim Chief Financial Officer</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>d765454dex991.htm
<DESCRIPTION>EX-99.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.1 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="right">


<IMG SRC="g765454dsp26.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>MiMedx Urges Shareholders to Vote Today &#147;FOR&#148; All of the Board&#146;s Highly Qualified </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Nominees on the BLUE Proxy Card </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>The MiMedx Annual Meeting is This Coming Monday, June&nbsp;17, 2019 </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">MARIETTA, Ga., June&nbsp;14, 2019 &#151; MiMedx Group, Inc. (OTC PINK: MDXG) (&#147;MiMedx&#148; or the &#147;Company&#148;), an industry leader in advanced
wound care and an emerging therapeutic biologics company, encourages shareholders to vote &#147;<B>FOR</B>&#148; all of the Board&#146;s highly qualified nominees online or by telephone by following the easy instructions on the <B>BLUE</B> Proxy
Card. The 2018 Annual Meeting of Shareholders (the &#147;Annual Meeting&#148;) will be held on Monday, June&nbsp;17, 2019 &#150; shareholders are urged to vote the <B>BLUE</B> proxy card TODAY. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Vote FOR Board Refreshment and FOR MiMedx&#146;s New, Experienced and Objective Nominees. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The MiMedx Board of Directors has developed a comprehensive plan to refresh the composition of the Board in the near term while providing important business
oversight and leadership continuity. None of the incumbent directors whose terms expire at the Annual Meeting or the 2019 annual meeting of shareholders will stand for reelection. In their stead, the Board will nominate or appoint six new directors,
including our new CEO. Two of the candidates standing for election at the upcoming Annual Meeting were identified by one of the Company&#146;s largest shareholders, Prescience Point Capital Management LLC. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">MiMedx&#146;s plan to refresh the composition of the Board with directors that will provide important business oversight and leadership can be implemented
<B>ONLY</B> if you vote on the <B>BLUE</B> proxy card &#147;FOR&#148; all of MiMedx&#146;s nominees. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>In the Company&#146;s View, Mr.&nbsp;Petit Cannot
Be Allowed to Return to MiMedx In </B><B><I>Any</I></B><B> Capacity. </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Board unanimously opposes the return of Parker H. &#147;Pete&#148; Petit to
the Company in any capacity. In its independent investigation conducted with the assistance of King&nbsp;&amp; Spalding LLP, a nationally recognized law firm, and KPMG LLP, which performed forensic accounting work, the Audit Committee of the Board
found that the evidence demonstrated that Mr.&nbsp;Petit and certain members of his management team engaged in material misconduct, which harmed MiMedx and its shareholders. The MiMedx Board unanimously recommends that shareholders do <B>NOT</B>
sign the white proxy card sent to you by, or on behalf of, Mr.&nbsp;Petit or his nominees. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>All Three Leading Proxy Advisory Firms Recommend
Shareholders Vote the BLUE Proxy Card. </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Institutional Shareholder Services (&#147;ISS&#148;), Glass, Lewis&nbsp;&amp; Co. (&#147;Glass Lewis&#148;) and
Egan-Jones Proxy Services all recommended MiMedx shareholders <B>vote FOR</B> the Company&#146;s three director nominees on the <B>BLUE</B> proxy card and have indicated that they believe that Mr.&nbsp;Petit&#146;s return to MiMedx would be damaging
to the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In its report dated June&nbsp;10, 2019, ISS noted the following<SUP STYLE="font-size:85%; vertical-align:top">1</SUP>: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">&#147;The company&#146;s slate would add the current CEO (Wright), a highly qualified chair of the board (Behrens
Wilsey), and a new chair of the audit committee (Newton), all of whom show competence and relevant experience. Of equal importance, the management nominees are new to the company and untainted by any wrongdoing that might have taken place in prior
years.&#148; </P></TD></TR></TABLE>
</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="right">


<IMG SRC="g765454dsp26.jpg" ALT="LOGO">
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In its report dated June&nbsp;11, 2019, Glass Lewis
concluded<SUP STYLE="font-size:85%; vertical-align:top">1</SUP>: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">&#147;We&#146;re of the opinion that a return of Mr.&nbsp;Petit to the boardroom would be <FONT
STYLE="white-space:nowrap">ill-advised,</FONT> send the wrong message to the Company&#146;s investors, customers, employees and regulators, and represent a very concerning step backwards just when the Company seems poised to return its focus on
rebuilding investor trust and confidence and growing its business.&#148; </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Both ISS and Glass Lewis recommended that shareholders <B>vote
AGAINST</B> the two shareholder proposals submitted by Mr.&nbsp;Petit. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Shareholders can vote by following the easy instructions on
the<B>&nbsp;BLUE</B>&nbsp;proxy card.<B>&nbsp;With the annual meeting only days away, MiMedx shareholders are encouraged to vote now </B><B><U>online or by telephone</U></B><B> to ensure their shares are represented at the Annual Meeting.
</B>Shareholders who have already voted using a white proxy card have the right to change their vote and can do so by following the easy instructions on the<B>&nbsp;BLUE</B>&nbsp;proxy card.&nbsp;Only the last dated vote will count. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company reminds shareholders that all materials regarding the Board&#146;s recommendations for the Annual Meeting are available at
<U>https://voteblueformimedx.com</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Your Vote Is Important, No Matter How Many Or How Few Shares You Own. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">If you have questions about how to vote your shares, or need additional assistance, please contact</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">the firm assisting MiMedx in the solicitation of proxies: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>INNISFREE M&amp;A INCORPORATED </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Shareholders may call toll-free at 1 (877) <FONT STYLE="white-space:nowrap">800-5195</FONT> </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Banks and Brokers may call 1 (212) <FONT STYLE="white-space:nowrap">750-5833</FONT> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Sidley Austin LLP is acting as legal advisor to MiMedx. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About MiMedx </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">MiMedx<SUP
STYLE="font-size:85%; vertical-align:top">&reg;</SUP> is an industry leader in advanced wound care and an emerging therapeutic biologics company developing and distributing human placental tissue allografts with patent-protected processes for
multiple sectors of healthcare. The Company processes the human placental tissue utilizing its proprietary PURION<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP> process methodology, among other processes, to produce allografts by
employing aseptic processing techniques in addition to terminal sterilization. MiMedx has supplied over 1.5&nbsp;million allografts to date. For additional information, please visit www.mimedx.com. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Safe Harbor </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This communication includes forward-looking
statements, including statements regarding the plan of MiMedx Group, Inc. (the &#147;<B><I>Company</I></B>&#148;) to refresh the Board. Forward-looking statements may be identified by words such as &#147;believe,&#148; &#147;expect,&#148;
&#147;may,&#148; &#147;plan,&#148; &#147;potential,&#148; &#147;will,&#148; &#147;would&#148; and similar expressions and are based on current beliefs and expectations. Forward-looking statements are subject to risks and uncertainties, and the
Company cautions investors against placing undue reliance on such </P>
</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="right">


<IMG SRC="g765454dsp26.jpg" ALT="LOGO">
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
statements. Actual results may differ materially from those set forth in the forward-looking statements as a result of various factors, including the results of any election at the Company&#146;s
2018 annual meeting of shareholders (the &#147;2018 Annual Meeting&#148;) or the Company&#146;s 2019 annual meeting of shareholders (the &#147;2019 Annual Meeting&#148;). There is no assurance that the Board&#146;s nominees will be elected at the
2018 Annual Meeting or the 2019 Annual Meeting. Any forward-looking statements speak only as of the date of this communication, and except as required by law, the Company assumes no obligation to update any forward-looking statement, whether as a
result of new information, future events or otherwise. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Contacts </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Investors: </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Hilary Dixon </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Corporate&nbsp;&amp; Investor Communications </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">770.651.9066 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">investorrelations@mimedx.com </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Media: </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Joele Frank, Wilkinson Brimmer Katcher </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Andy Brimmer / Jed Repko
/ Annabelle Rinehart </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">212.355.4449 </P> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:10%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">1</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Permission to use quotations neither sought nor obtained. </P></TD></TR></TABLE>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g765454dsp26.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g765454dsp26.jpg
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M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
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M4NU!&Y>:&/#_ ,';RT9<7#PB6;_?++D?AP/PKG57VN*4O,W=/V>':.?^$/\
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!V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
